Specialist oncology consulting for biopharma sponsors and CROs — from protocol feasibility and I/E translation to site readiness assessment and ongoing trial liaison. Grounded in real site operations, not theory.
Oncology protocols are operationally dense — narrow eligibility windows, biomarker gating, complex dosing schedules, and sites that may have never run your tumour type before. Our consulting services are designed for sponsors and CROs that need focused, rapid-turnaround expertise grounded in how oncology sites actually operate: what questions site coordinators ask, where recruitment stalls, and how to fix it before it costs you enrolment.
Rapid operational assessment of whether a protocol can realistically recruit at a given site or site network.
Transform dense eligibility criteria into patient-accessible language that improves accrual without compromising protocol integrity.
Structured evaluation of an investigative site's operational readiness before trial activation — reducing site-initiation delays and SSU timelines.
Ongoing independent support for CROs and sponsors identifying, evaluating, and activating oncology investigative sites across the US.
All project fees are confirmed after a brief scoping call. Custom engagements and multi-protocol packages available on request.
Complete the enquiry form below with your protocol name, service needed, and timeline. No lengthy RFP — a paragraph describing the challenge is enough to get started.
We'll confirm scope, agree deliverable format, sign an NDA if required, and provide a fixed project fee within 24 hours. No retainer required for project-based work.
Work is completed to the agreed timeline — typically 3–10 business days. All documents are reviewed for accuracy and formatted for direct use by your clinical operations team.
Tell us what you're working on — protocol name, the challenge you're facing, and your timeline. We'll respond within one business day with a scoping call invitation or, for straightforward requests, a direct fee proposal.
Enquiries are treated as confidential. We routinely operate under NDA from day one of any engagement and will sign your preferred form if required.
Response commitment: All enquiries receive a substantive response within one business day (Monday–Friday, US Central time). For urgent feasibility requests or pre-submission timelines, note that in your message and we will prioritise accordingly.
Prefer a direct conversation?
All consulting work is performed to GCP/ICH E6(R3) standards with reference to applicable FDA regulations.